Traditional Chinese medicine composition for treating hepatorenal syndrome caused by Yang deficiency of liver and kidney

Abstract

The invention belongs to the technical field of medicine and particularly relates to a traditional Chinese medicine composition for treating hepatorenal syndrome caused by Yang deficiency of the liver and the kidney. The traditional Chinese medicine composition is prepared from, by weight, 4-8 parts of fructus foeniculi, 4-8 parts of cinnamomum cassia, 4-8 parts of fruits of argy wormwood, 4-8 parts of aspongopus, 4-8 parts of seeds of dill, 4-8 parts of desmodium triflorum, 4-8 parts of cinnamomum wilsonii, 4-8 parts of acanthopanax henryi and 4-8 parts of radix glycyrrhizae. All medial materials are combined to jointly achieve the effects of warming the kidney and the liver and regulating qi to alleviate pain; the traditional Chinese medicine composition can effectively improve clinical symptoms and body signs of a patient, lower the level of blood urea nitrogen, the level of creatinine and the level of urine protein and raise the glomerular filtration rate and meanwhile can lower the level of glutamic-pyruvic transaminase and the level of glutamic oxalacetic transaminase and improve the function of the liver.

Description

technical field [0001] The invention belongs to the technical field of medicines, and in particular relates to a traditional Chinese medicine composition for treating liver-kidney yang-deficiency type hepatorenal syndrome. Background technique [0002] Hepatorenal syndrome (HRS) refers to a functional renal failure in patients with severe liver diseases such as cirrhosis and severe viral hepatitis without clear primary renal disease. It was first proposed by Helwig in 1932. At that time, it was used to describe acute renal failure after biliary obstruction surgery. Later, it was used to refer to all diseases involving the liver and kidney at the same time. At present, it often refers to liver cirrhosis, fulminant hepatic failure, severe viral hepatitis, primary Functional renal failure secondary to severe liver disease such as primary or secondary liver cancer. There are no primary and specific organic lesions in the kidneys of patients with hepatorenal syndrome, and there ...

AI Technical Summary

Problems solved by technology

At present, the pathogenesis of hepatorenal syndrome is not fully understood by Western medicine, and there is no effective treatment for it.